-
Something wrong with this record ?
Protective effect of ginsenoside against acute renal failure and expression of tyrosine hydroxylase in the locus coeruleus
H. A. Zhang, M. Wang, J. Zhou, Q. Y. Yao, J. M. Ma, C. L. Jiang
Language English Country Czech Republic
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Acute Kidney Injury MeSH
- Administration, Oral MeSH
- Biomarkers blood MeSH
- Time Factors MeSH
- Water Deprivation MeSH
- Blood Urea Nitrogen MeSH
- Financing, Organized MeSH
- Phosphorylation MeSH
- Ginsenosides administration & dosage pharmacology MeSH
- Glutathione metabolism MeSH
- Glycerol MeSH
- Immunohistochemistry MeSH
- Creatinine blood MeSH
- Rats MeSH
- Kidney MeSH
- Locus Coeruleus enzymology drug effects MeSH
- Malondialdehyde metabolism MeSH
- Mitogen-Activated Protein Kinase 1 metabolism MeSH
- Mitogen-Activated Protein Kinase 3 metabolism MeSH
- Disease Models, Animal MeSH
- Protective Agents administration & dosage pharmacology MeSH
- Lipid Peroxidation drug effects MeSH
- Rats, Sprague-Dawley MeSH
- Tyrosine 3-Monooxygenase metabolism MeSH
- Up-Regulation MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
Acute renal failure (ARF) is mainly characterized by acute tubular necrosis. No significant change was found for mortality rates over the past few decades despite significant advances in supportive care. In recent years, great effort has been focused on traditional and herbal medicine, which is much less toxic than those agents conventionally used and which is nowadays considered as a novel therapeutic agent for ARF. However, the effect of ginsenosides (GS) administered orally on ARF has not been reported yet and little is known about its cellular and molecular mechanism. The purpose of the study is to investigate the protective effect of ginsenoside in rats with ARF on the changes of tyrosine hydroxylase immunoreactivity (TH-IR) as well as on the involvement of mitogen-activated protein kinases (MAPK) in the locus coeruleus. In our assay, glycerol-induced acute renal failure in rats was employed to study the protective effects of ginsenoside. Our results indicated that the treatment of ARF rats with ginsenosides for 48 h significantly reduced the serum blood urea nitrogen, creatinine level, and lipid peroxidation, restored the GSH level and the normal renal morphology. Immunohistochemistry showed that an obvious increase of TH-IR was further enhanced in ARF+GS group. The same effect was also observed in the changes of p-ERK1/2-IR in the locus coeruleus. Our results suggest that ginsenoside administered orally may have a strong renal protective effect against glycerol-induced ARF, and ginsenoside can also activate the brain catecholaminergic neurons in the locus coeruleus. Our future attention will be focused to the question whether there is a correlation between the renal protective effect of ginsenosides against acute renal failure and the activation of tyrosine hydroxylase in the locus coeruleus.
References provided by Crossref.org
Lit.: 39
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10013107
- 003
- CZ-PrNML
- 005
- 20111210173637.0
- 008
- 100601s2010 xr e eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.931650 $2 doi
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Zhang, H. A.
- 245 10
- $a Protective effect of ginsenoside against acute renal failure and expression of tyrosine hydroxylase in the locus coeruleus / $c H. A. Zhang, M. Wang, J. Zhou, Q. Y. Yao, J. M. Ma, C. L. Jiang
- 314 __
- $a Department of Physiology, Dalian Medical University, Dalian
- 504 __
- $a Lit.: 39
- 520 9_
- $a Acute renal failure (ARF) is mainly characterized by acute tubular necrosis. No significant change was found for mortality rates over the past few decades despite significant advances in supportive care. In recent years, great effort has been focused on traditional and herbal medicine, which is much less toxic than those agents conventionally used and which is nowadays considered as a novel therapeutic agent for ARF. However, the effect of ginsenosides (GS) administered orally on ARF has not been reported yet and little is known about its cellular and molecular mechanism. The purpose of the study is to investigate the protective effect of ginsenoside in rats with ARF on the changes of tyrosine hydroxylase immunoreactivity (TH-IR) as well as on the involvement of mitogen-activated protein kinases (MAPK) in the locus coeruleus. In our assay, glycerol-induced acute renal failure in rats was employed to study the protective effects of ginsenoside. Our results indicated that the treatment of ARF rats with ginsenosides for 48 h significantly reduced the serum blood urea nitrogen, creatinine level, and lipid peroxidation, restored the GSH level and the normal renal morphology. Immunohistochemistry showed that an obvious increase of TH-IR was further enhanced in ARF+GS group. The same effect was also observed in the changes of p-ERK1/2-IR in the locus coeruleus. Our results suggest that ginsenoside administered orally may have a strong renal protective effect against glycerol-induced ARF, and ginsenoside can also activate the brain catecholaminergic neurons in the locus coeruleus. Our future attention will be focused to the question whether there is a correlation between the renal protective effect of ginsenosides against acute renal failure and the activation of tyrosine hydroxylase in the locus coeruleus.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a aplikace orální $7 D000284
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a dusík močoviny v krvi $7 D001806
- 650 _2
- $a kreatinin $x krev $7 D003404
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a ginsenosidy $x aplikace a dávkování $x farmakologie $7 D036145
- 650 _2
- $a glutathion $x metabolismus $7 D005978
- 650 _2
- $a glycerol $7 D005990
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a ledviny $7 D007668
- 650 _2
- $a akutní poškození ledvin $7 D058186
- 650 _2
- $a peroxidace lipidů $x účinky léků $7 D015227
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a malondialdehyd $x metabolismus $7 D008315
- 650 _2
- $a mitogenem aktivovaná proteinkinasa 1 $x metabolismus $7 D019950
- 650 _2
- $a mitogenem aktivovaná proteinkinasa 3 $x metabolismus $7 D048052
- 650 _2
- $a fosforylace $7 D010766
- 650 _2
- $a ochranné látky $x aplikace a dávkování $x farmakologie $7 D020011
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Sprague-Dawley $7 D017207
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a tyrosin-3-monooxygenasa $x metabolismus $7 D014446
- 650 _2
- $a upregulace $7 D015854
- 650 _2
- $a deprivace z nedostatku vody $7 D014868
- 650 _2
- $a locus coeruleus $x enzymologie $x účinky léků $7 D008125
- 700 1_
- $a Wang, M.
- 700 1_
- $a Zhou, J.
- 700 1_
- $a Yao, Q. Y.
- 700 1_
- $a Ma, J. M.
- 700 1_
- $a Jiang, C. L.
- 773 0_
- $w MED00003824 $t Physiological research $g Roč. 59, č. 1 (2010), s. 61-70 $x 0862-8408
- 856 41
- $u http://www.biomed.cas.cz/physiolres/pdf/59/59_61.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 8
- 990 __
- $a 20100601135354 $b ABA008
- 991 __
- $a 20101123155353 $b ABA008
- 999 __
- $a ok $b bmc $g 741232 $s 604715
- BAS __
- $a 3
- BMC __
- $a 2010 $b 59 $c 1 $d 61-70 $m Physiological research $x MED00003824
- LZP __
- $a 2010-15/mkme